Literature DB >> 17659431

Modulation of the inflammatory response by estrogens with focus on the endothelium and its interactions with leukocytes.

B-O Nilsson1.   

Abstract

Gender differences and variations in inflammatory disease (e. g. atherosclerosis, neurological disorders, periodontitis and rheumatoid arthritis) severity with female sex hormone level have been reported, suggesting that female sex hormones modulate the inflammatory response. Estrogens act on gene transcription via estrogen receptors alpha and beta. Identification of estrogen-regulated genes is a matter of great interest since it will contribute significantly to the understanding of the physiological importance of estrogens. Anti-inflammatory as well as pro-inflammatory responses to estrogens have been reported. Data have been presented showing that estrogens down-regulate the expression of adhesion and chemokine molecules in response to inflammation promoters in various experimental systems. Functional data show that estrogen treatment attenuates recruitment and adhesion of leukocytes to the endothelium induced by inflammation promoters offering a possible mechanism by which estrogens exert an anti-inflammatory effect. These effects of estrogens, with focus on the interactions of monocytes with the vascular endothelium, are highlighted in this review.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17659431     DOI: 10.1007/s00011-007-6198-z

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  27 in total

1.  Effects of progesterone and estradiol sex hormones on the release of microparticles by RAW 264.7 macrophages stimulated by Poly(I:C).

Authors:  David S Pisetsky; Diane M Spencer
Journal:  Clin Vaccine Immunol       Date:  2011-06-08

2.  A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease.

Authors:  J E Eaton; B D Juran; E J Atkinson; E M Schlicht; X Xie; M de Andrade; C S Lammert; V A Luketic; J A Odin; A A Koteish; K V Kowdley; K B Chopra; G M Hirschfield; N P Chalasani; K N Lazaridis
Journal:  Aliment Pharmacol Ther       Date:  2015-03-17       Impact factor: 8.171

Review 3.  Sex differences in innate immunity and its impact on opioid pharmacology.

Authors:  Hillary H Doyle; Anne Z Murphy
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

4.  Angiotensin (1-7) ameliorates angiotensin II-induced inflammation by inhibiting LOX-1 expression.

Authors:  Lijun Wang; Xuesong Hu; Wenwu Zhang; Fang Tian
Journal:  Inflamm Res       Date:  2012-12-12       Impact factor: 4.575

5.  A pathway approach to evaluating the association between the CHIEF pathway and risk of colorectal cancer.

Authors:  Martha L Slattery; Roger K Wolff; Abbie Lundgreen
Journal:  Carcinogenesis       Date:  2014-10-20       Impact factor: 4.944

6.  Pregnancy-induced gingivitis and OMICS in dentistry: in silico modeling and in vivo prospective validation of estradiol-modulated inflammatory biomarkers.

Authors:  Mervi Gürsoy; Fares Zeidán-Chuliá; Eija Könönen; José C F Moreira; Joonas Liukkonen; Timo Sorsa; Ulvi K Gürsoy
Journal:  OMICS       Date:  2014-07-01

7.  The G protein-coupled oestrogen receptor 1 agonist G-1 disrupts endothelial cell microtubule structure in a receptor-independent manner.

Authors:  Anders Holm; Per-Olof Grände; Richard F Ludueña; Björn Olde; Veena Prasad; L M Fredrik Leeb-Lundberg; Bengt-Olof Nilsson
Journal:  Mol Cell Biochem       Date:  2012-03-27       Impact factor: 3.396

8.  Influence of gender and oral contraceptives intake on innate and inflammatory response. Role of neuroendocrine factors.

Authors:  E Giraldo; M D Hinchado; J J Garcia; Eduardo Ortega
Journal:  Mol Cell Biochem       Date:  2008-04-10       Impact factor: 3.396

Review 9.  Convergence of hormones, inflammation, and energy-related factors: a novel pathway of cancer etiology.

Authors:  Martha L Slattery; F A Fitzpatrick
Journal:  Cancer Prev Res (Phila)       Date:  2009-11

Review 10.  Why are women predisposed to autoimmune rheumatic diseases?

Authors:  Jacqueline E Oliver; Alan J Silman
Journal:  Arthritis Res Ther       Date:  2009-10-26       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.